Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions.

Herzog, Thomas J; Wahab, Shaun A; Mirza, Mansoor R; Pothuri, Bhavana; Vergote, Ignace; Graybill, Whitney S; Malinowska, Izabela A; York, Whitney; Hurteau, Jean A; Gupta, Divya; González-Martin, Antonio; Monk, Bradley J.

Int J Gynecol Cancer ; 33(11): 1733-1742, 2023 11 06.

Artículo en Inglés | MEDLINE | ID: mdl-37931976

2.

Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery.

Kim, Josephine S; Liang, Margaret I; Prendergast, Emily N; Alldredge, Jill; Datta, Avisek; Hurteau, Jean A; Kirschner, Carolyn V; Rodriguez, Gustavo; Vogel, Tilley J; Brooks, Rebecca A; Cass, Ilana; Cohen, Joshua G; Penner, Kristine R; Wang, Chi E; Diaz Moore, Elena S.

Int J Gynecol Cancer ; 29(7): 1156-1163, 2019 09.

Artículo en Inglés | MEDLINE | ID: mdl-31352365

3.

Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.

Kim, Josephine S; Mills, Kathryn A; Fehniger, Julia; Liao, Chuanhong; Hurteau, Jean A; Kirschner, Carolyn V; Lee, Nita K; Rodriguez, Gustavo C; Yamada, S Diane; Diaz Moore, Elena S; Tenney, Meaghan E.

Int J Gynecol Cancer ; 27(8): 1774-1782, 2017 10.

Artículo en Inglés | MEDLINE | ID: mdl-28708786

4.

Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary.

Glasspool, Rosalind M; González Martín, Antonio; Millan, David; Lorusso, Domenica; Åvall-Lundqvist, Elisabeth; Hurteau, Jean A; Davis, Alison; Hilpert, Felix; Kim, Jae-Weon; Alexandre, Jérôme; Ledermann, Jonathan A.

Int J Gynecol Cancer ; 24(9 Suppl 3): S26-9, 2014 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-25126954

5.

Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting.

Rimel, Bobbie J; Chase, Dana M; Perhanidis, Jessica; Ghazarian, Armen A; Du, Ella Xiaoyan; Wang, Travis; Song, Jinlin; Golembesky, Amanda K; Hurteau, Jean A; Kalilani, Linda; Salani, Ritu; Monk, Bradley J.

Gynecol Oncol Rep ; 51: 101332, 2024 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-38362364

6.

Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells.

Damania, Dhwanil; Roy, Hemant K; Kunte, Dhananja; Hurteau, Jean A; Subramanian, Hariharan; Cherkezyan, Lusik; Krosnjar, Nela; Shah, Maitri; Backman, Vadim.

Int J Cancer ; 133(5): 1143-52, 2013 Sep 01.

Artículo en Inglés | MEDLINE | ID: mdl-23436651

7.

Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer.

Chan, John K; Liu, Jinan; Song, Jinlin; Xiang, Cheryl; Wu, Eric; Kalilani, Linda; Hurteau, Jean A; Thaker, Premal H.

Am J Clin Oncol ; 46(7): 314-322, 2023 07 01.

Artículo en Inglés | MEDLINE | ID: mdl-37106485

8.

Omitting lymphadenectomy in patients with endometrial cancer.

Hurteau, Jean A.

Cancer ; 123(2): 197-199, 2017 01 01.

Artículo en Inglés | MEDLINE | ID: mdl-28067947

9.

Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells.

Rodriguez, Gustavo C; Turbov, Jane M; Berchuck, Andrew; Stack, M Sharon; Hurteau, Jean A; Thaete, Larry G; Barry, Catherine P.

Am J Obstet Gynecol ; 206(3): 253.e1-9, 2012 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-22206747

10.

Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States.

Liu, Jinan; Emond, Bruno; Maiese, Eric M; Lafeuille, Marie-Hélène; Lefebvre, Patrick; Ghelerter, Isabelle; Wu, Caterina; Hurteau, Jean A; Thaker, Premal H.

Curr Med Res Opin ; 38(11): 1935-1945, 2022 11.

Artículo en Inglés | MEDLINE | ID: mdl-35975577

11.

Germ cell tumors: Treatment consensus across all age groups through MaGIC [Malignant Germ Cell International Collaborative].

Hurteau, Jean A; Febbraro, Terri.

Cancer ; 122(2): 181-3, 2016 Jan 15.

Artículo en Inglés | MEDLINE | ID: mdl-26485495

12.

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.

Usha, Lydia; Sill, Michael W; Darcy, Kathleen M; Benbrook, Doris M; Hurteau, Jean A; Michelin, David P; Mannel, Robert S; Hanjani, Parviz; De Geest, Koen; Godwin, Andrew K.

Gynecol Oncol ; 121(3): 455-61, 2011 Jun 01.

Artículo en Inglés | MEDLINE | ID: mdl-21414654

13.

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study.

Hurteau, Jean A; Brady, Mark F; Darcy, Kathleen M; McGuire, William P; Edmonds, Pamela; Pearl, Michael L; Ivanov, Iouri; Tewari, Krishnansu S; Mannel, Robert S; Zanotti, Kristine; Benbrook, Doris M.

Gynecol Oncol ; 119(3): 444-50, 2010 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-20846715

14.

The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.

Weinberg, Lori E; Rodriguez, Gustavo; Hurteau, Jean A.

J Surg Oncol ; 101(4): 334-43, 2010 Mar 15.

Artículo en Inglés | MEDLINE | ID: mdl-20187069

15.

Cardiac metastasis from poorly differentiated carcinoma of the cervix: a case report.

Miller, Emily S; Hoekstra, Anna V; Hurteau, Jean A; Rodriguez, Gustavo C.

J Reprod Med ; 55(1-2): 78-80, 2010.

Artículo en Inglés | MEDLINE | ID: mdl-20337214

16.

The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.

Hoekstra, Anna V; Hurteau, Jean A; Kirschner, Carolyn V; Rodriguez, Gustavo C.

Gynecol Oncol ; 115(3): 377-81, 2009 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-19800107

17.

Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer.

Sharma, Arun; Belna, Jennifer; Espat, Joseph; Rodriguez, Gustavo; Cannon, Vernon T; Hurteau, Jean A.

Am J Obstet Gynecol ; 200(5): 516.e1-6, 2009 May.

Artículo en Inglés | MEDLINE | ID: mdl-19268879

18.

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.

Mell, Loren K; Kochanski, Joel D; Roeske, John C; Haslam, Josh J; Mehta, Neil; Yamada, S Diane; Hurteau, Jean A; Collins, Yvonne C; Lengyel, Ernst; Mundt, Arno J.

Int J Radiat Oncol Biol Phys ; 66(5): 1356-65, 2006 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-16757127

19.

Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy.

Ezewuiro, Obiageli; Grushko, Tatyana A; Kocherginsky, Masha; Habis, Mohammed; Hurteau, Jean A; Mills, Kathryn A; Hunn, Jessica; Olopade, Olufunmilayo I; Fleming, Gini F; Romero, Iris L.

PLoS One ; 11(1): e0147145, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-26788855

20.

Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients.

Schroder, Maryann; Mell, Loren K; Hurteau, Jean A; Collins, Yvonne C; Rotmensch, Jacob; Waggoner, Steven E; Yamada, S Diane; Small, William; Mundt, Arno J.

Int J Radiat Oncol Biol Phys ; 61(4): 1078-86, 2005 Mar 15.

Artículo en Inglés | MEDLINE | ID: mdl-15752887

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: